4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide

C56H69BrN9O10+ — CID 163649707

IUPAC4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide
SMILESC#CCN(Cc1cc2c(=O)[nH]c(C)nc2cc1Br)c1ccc(C(=O)NCc2ccc[n+](Cc3ccc(NC(=O)[C@H](CCCNC(N)=O)CC(=O)[C@@H](NC(=O)CCOCCOCCOCCC(C)=O)C(C)C)cc3)c2)cc1
InChIInChI=1S/C56H68BrN9O10/c1-6-22-66(36-44-30-47-49(32-48(44)57)61-39(5)62-55(47)72)46-17-13-42(14-18-46)53(70)60-33-41-9-8-23-65(35-41)34-40-11-15-45(16-12-40)63-54(71)43(10-7-21-59-56(58)73)31-50(68)52(37(2)3)64-51(69)20-25-75-27-29-76-28-26-74-24-19-38(4)67/h1,8-9,11-18,23,30,32,35,37,43,52H,7,10,19-22,24-29,31,33-34,36H2,2-5H3,(H6-,58,59,60,61,62,63,64,69,70,71,72,73)/p+1/t43-,52+/m1/s1
InChIKeyAQZAGKRNXWFZNH-LBDNRBHXSA-O
MW1108.12 g/mol
LogP5.42
Rot. Bonds32

About 4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide

4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide (PubChem CID 163649707) has the molecular formula C56H69BrN9O10+ and a molecular weight of 1108.12 g/mol. Its IUPAC name is 4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide.

Molecular Properties

Compound Name4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide
PubChem CID163649707
Molecular FormulaC56H69BrN9O10+
Molecular Weight1108.12 g/mol
Exact Mass1106.43
IUPAC Name4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide
SMILESC#CCN(Cc1cc2c(=O)[nH]c(C)nc2cc1Br)c1ccc(C(=O)NCc2ccc[n+](Cc3ccc(NC(=O)[C@H](CCCNC(N)=O)CC(=O)[C@@H](NC(=O)CCOCCOCCOCCC(C)=O)C(C)C)cc3)c2)cc1
InChIInChI=1S/C56H68BrN9O10/c1-6-22-66(36-44-30-47-49(32-48(44)57)61-39(5)62-55(47)72)46-17-13-42(14-18-46)53(70)60-33-41-9-8-23-65(35-41)34-40-11-15-45(16-12-40)63-54(71)43(10-7-21-59-56(58)73)31-50(68)52(37(2)3)64-51(69)20-25-75-27-29-76-28-26-74-24-19-38(4)67/h1,8-9,11-18,23,30,32,35,37,43,52H,7,10,19-22,24-29,31,33-34,36H2,2-5H3,(H6-,58,59,60,61,62,63,64,69,70,71,72,73)/p+1/t43-,52+/m1/s1
InChIKeyAQZAGKRNXWFZNH-LBDNRBHXSA-O
XLogP5.42
TPSA257.12 Ų
H-Bond Donors6
H-Bond Acceptors12
Rotatable Bonds32
Heavy Atoms76
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001108.12
LogP ≤ 55.42
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide?
The IUPAC name of 4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide (CID 163649707) is 4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide.
What is the SMILES notation for 4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide?
The canonical SMILES for 4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide is C#CCN(Cc1cc2c(=O)[nH]c(C)nc2cc1Br)c1ccc(C(=O)NCc2ccc[n+](Cc3ccc(NC(=O)[C@H](CCCNC(N)=O)CC(=O)[C@@H](NC(=O)CCOCCOCCOCCC(C)=O)C(C)C)cc3)c2)cc1.
What is the InChIKey of 4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide?
The InChIKey is AQZAGKRNXWFZNH-LBDNRBHXSA-O. The full InChI is InChI=1S/C56H68BrN9O10/c1-6-22-66(36-44-30-47-49(32-48(44)57)61-39(5)62-55(47)72)46-17-13-42(14-18-46)53(70)60-33-41-9-8-23-65(35-41)34-40-11-15-45(16-12-40)63-54(71)43(10-7-21-59-56(58)73)31-50(68)52(37(2)3)64-51(69)20-25-75-27-29-76-28-26-74-24-19-38(4)67/h1,8-9,11-18,23,30,32,35,37,43,52H,7,10,19-22,24-29,31,33-34,36H2,2-5H3,(H6-,58,59,60,61,62,63,64,69,70,71,72,73)/p+1/t43-,52+/m1/s1.
What are the key properties of 4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide?
4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide has a molecular weight of 1108.12 g/mol, XLogP of 5.42, 32 rotatable bonds, 6 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-[[1-[[4-[[(2R,5S)-2-[3-(carbamoylamino)propyl]-6-methyl-4-oxo-5-[3-[2-[2-(3-oxobutoxy)ethoxy]ethoxy]propanoylamino]heptanoyl]amino]phenyl]methyl]pyridin-1-ium-3-yl]methyl]benzamide is sourced from PubChem (CID 163649707), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).